Mahindra Lifespace Developers Ltd reported a substantial surge in net profit for the first quarter of FY26, driven by increased project deliveries and efficient cost management. The company’s consolidated net profit jumped over fourfold to Rs. 55.2 crore, a sharp rise from Rs. 13.4 crore in the same quarter last year. However, this growth came amid a dip in consolidated revenue, which fell to Rs. 255.4 crore from Rs. 255.7 crore.

Mumbai-based Arkade Developers reported a modest decline in net profit for the first quarter of FY26, with earnings slipping 5% year-on-year to Rs. 29 crore. The drop in profitability was primarily driven by elevated construction input costs and subdued growth in new bookings, despite stable revenue from ongoing projects. The company, which has a growing footprint in the Mumbai Metropolitan Region (MMR), remains focused on expanding its development portfolio while navigating regulatory hurdles and volatile raw material prices.

HFCL Ltd., a leading Indian telecom and technology solutions provider, reported a consolidated net loss of Rs. 32 crore in the first quarter of FY26, reversing a profit of Rs. 75 crore in the same period last year. The company also saw a significant decline in its revenue from operations, which fell by over 36% year-on-year to Rs. 727 crore. Management attributed the downturn to sluggish demand in optical fiber cable exports and reduced government orders, even as the company maintains confidence in its long-term strategy and product pipeline.

---

Cholamandalam MS General Insurance, a joint venture between the Murugappa Group and Japan's Mitsui Sumitomo Insurance, has reported a strong financial performance for the first quarter of FY26. The company’s net profit surged 29% year-on-year to Rs. 126 crore, supported by improved underwriting practices, disciplined cost controls, and healthy investment income. Gross written premiums also rose substantially, reflecting continued momentum in motor and health insurance segments.

Dr. Reddy’s Laboratories reported a modest 1% year-on-year increase in consolidated net profit for the first quarter, reaching Rs. 1,410 crore. The pharmaceutical major saw its revenue grow by 10% during the same period, driven largely by its North America and emerging markets operations. Despite pricing pressure and regulatory headwinds in key geographies, the company maintained operational resilience through strategic launches and sustained product momentum. With a diversified global footprint and a focus on innovation, Dr.

Kaytex Fabrics, a company operating in the textile manufacturing and trading sector, is set to open its initial public offering (IPO) for subscription on July 29. The IPO price band is fixed between Rs. 171 and Rs. 180 per share, signaling investor confidence in the company’s valuation. Through this issue, Kaytex aims to raise fresh capital to support business expansion, strengthen its balance sheet, and fund working capital requirements.

Indian pharmaceutical major Glenmark Pharmaceuticals has received critical observations from the United States Food and Drug Administration (USFDA) following an inspection of its Baddi facility in Himachal Pradesh. The US regulator, after a routine audit, identified multiple lapses in the plant’s manufacturing practices, issuing a Form 483 with seven key observations. While the company has yet to receive any import restrictions or warning letters, the findings underscore the growing scrutiny faced by Indian drugmakers exporting to the United States.

Borosil Renewables Ltd, India’s leading solar glass manufacturer, reported a consolidated net loss of Rs. 272 crore for the first quarter, marking a significant downturn in its financial performance. The loss comes on the back of sustained pricing pressure from cheaper imports and muted domestic demand for solar components. While the company remains committed to long-term capacity expansion and localization, the near-term operating environment remains challenging.

Bharat Bijlee Ltd., a key player in India's electrical engineering sector, has announced a 16.51% year-on-year rise in its standalone net profit for the quarter ended June 2025. The company posted a net profit of Rs. 21.85 crore, driven by robust demand for industrial systems and improved operational margins. Revenue from operations rose to Rs. 271.53 crore, reflecting the company’s ability to efficiently execute large orders amid a volatile macroeconomic environment.

Aditya Birla Real Estate has reported a consolidated net loss of Rs. 27 crore for the first quarter of the fiscal year, reflecting the cost pressures and transitional expenses associated with its ongoing expansion strategy. Despite a robust pipeline of projects and long-term growth potential, the company faced higher operational expenses and delayed revenue recognition in certain developments.